Medicine and Dentistry
Gut Microbiome
93%
Metastatic Carcinoma
91%
Disease
76%
Choroidal Neovascularization
75%
Age Related Macular Degeneration
73%
Diagnosis
71%
Medicine
70%
Gut Microbiota
69%
Neoplasm
66%
Lymph Duct
65%
Epileptic Absence
65%
Organ Systems
65%
Programmed Death 1 Ligand 1
65%
Non Small Cell Lung Cancer
65%
Durvalumab
65%
Gut
58%
Circulating Tumor Cell
56%
Retina Disease
54%
Laser-Induced Choroidal Neovascularization
43%
Transcriptomics
39%
Retinal Pigment Epithelium
37%
Choroid
37%
Lipid Diet
35%
Wet Macular Degeneration
34%
Transcriptome
34%
Clinical Feature
32%
Chloroquine
32%
Hydroxychloroquine
32%
Catheter Ablation
32%
Cardiomyopathy
32%
Asthma
32%
Glycon
32%
Histopathology
32%
Cancer Stem Cell
32%
Ventricular Tachycardia
32%
Liquid Biopsy
32%
Tumor Progression
32%
Neuroprotection
32%
Morphology
32%
Myocardial Infarction
32%
Radiation Therapy
32%
Radiation Therapy
32%
Diagnostic Testing
32%
Carcinoid
32%
Cancer
32%
Small Cell Lung Cancer
32%
Chromothripsis
32%
Neuroendocrine Tumor
32%
Myopathy
28%
Nodular Melanoma
26%
Keyphrases
Educational Case
65%
Basic Competencies
65%
Age-related Macular Degeneration
65%
Therapeutic Pathology
65%
Tumor Protein p53 (TP53)
51%
Phase II Trial
37%
Tumor
37%
Learning Objectives
32%
Gut Microbiota
32%
Cardiac Metastasis
32%
Medical Education
32%
System Diagnostics
32%
Transcriptomic Changes
32%
Learning Tools
32%
Competencies
32%
Novel Therapeutics
32%
Diagnostic Medicine
32%
Pathology Competencies
32%
Disease Process
32%
National Standard
32%
Clinical Features
32%
Retinal Transcriptome
32%
Disease Mechanisms
32%
Retinal pigment Epithelium
32%
Therapeutic Candidates
32%
Asthma
32%
Organ System Pathology
32%
Pathobiology
32%
Bioinformatics Tools
32%
Myopic Choroidal Neovascularization (mCNV)
32%
Stage III Non-small Cell Lung Cancer
32%
Programmed Death-ligand 1 (PD-L1)
32%
Thoracic Radiation Therapy
32%
Durvalumab
32%
Malignancy
32%
Small Cell Lung Cancer
32%
Carcinoid Tumor
32%
Chromothripsis
32%
Previously Treated
32%
Exportin-1
32%
Non-small Cell Lung Cancer (NSCLC)
32%
Docetaxel
32%
Kirsten Rat Sarcoma Viral Oncogene
32%
Selinexor
32%
Well-differentiated Neuroendocrine Tumor
32%
Immunohistochemical Analysis
32%
Diagnostic pitfalls
32%
Clinicopathological Analysis
32%
Germ-free
19%
Patient Demography
16%
Pharmacology, Toxicology and Pharmaceutical Science
Age Related Macular Degeneration
100%
Intestine Flora
69%
Subretinal Neovascularization
65%
Non Small Cell Lung Cancer
65%
Programmed Death 1 Ligand 1
65%
Durvalumab
65%
Microbiome
57%
Disease
55%
Metformin
50%
Retina Disease
41%
Visual Pigment
37%
Neuroprotection
32%
Diabetes Mellitus
32%
Epileptic Absence
32%
Heart Infarction
32%
Vitreoretinopathy
32%
Connective Tissue Cancer
32%
Exportin 1
32%
Docetaxel
32%
Selinexor
32%
Lung Cancer
32%
Population Study
24%
Germfree Mouse
22%
Disease Exacerbation
21%
Pig Insulin
16%
Oral Antidiabetic Agent
16%
Non Insulin Dependent Diabetes Mellitus
16%
Progression Free Survival
13%
Mouse
13%
Microorganism
13%
Laser-Induced Choroidal Neovascularization
11%
Clinical Study
10%
Antioxidant
9%
Monotherapy
9%
Diseases
9%
Chemoradiation Therapy
9%
Chemotherapy
9%
Immune Checkpoint Inhibitor
9%
Acute Kidney Failure
9%
Neoplasm
9%
Overall Survival
9%
Dysbiosis
9%
Preclinical Study
9%
Infectious Agent
8%
Clinical Feature
8%
Cross-Sectional Study
8%
Glitazone Derivative
8%
Medical History
8%
Microflora
7%
Antidiabetic Agent
7%
